Intuitive Surgical Inc. (ISRG)
NASDAQ: ISRGHealth CareIndustrial SpecialtiesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ISRG stock chart
Technical analysisKey statistics
All statistics- Market cap
- $146.44B
- P/E (TTM)
- 47.54
- Forward P/E
- 34.23
- EPS (TTM)
- $8.72
- Dividend yield
- None
- 52-week range
- 328.57 – 603.88
- Day range
- 404.20 – 416.81
- Volume / Avg
- 1.90M / 2.93M
- Beta
- —
- Shares outstanding
- 353.28M
- Next earnings
- Oct 20, 2026
52-week range
ISRG stock today
Shares of Intuitive Surgical (ISRG) finished higher on Oct 7 at $414.52, a gain of 2.41% or $9.76 per share, versus the S&P 500's 0.22% decline. Shares are 31.4% below their 52-week high of $603.88, set on Jan 7, 2026 and 26.2% above the 52-week low of $328.57, in the middle of the past year's range. ISRG is down 26.8% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 6.0%.
At 47.5x trailing earnings, Intuitive Surgical trades above the peer-group median of 23.3x. Its forward P/E of 34.2x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. The company is scheduled to report Sep/2026 results on Oct 20 after the market closes; analysts expect EPS of $2.13.
Summary generated from market data by MetaCap's automated system. Methodology
About Intuitive Surgical
Company profileIntuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.
- Sector
- Health Care
- Industry
- Industrial Specialties
- CEO
- Mr. David J. Rosa
- Headquarters
- Sunnyvale, CA
- Employees
- 17,021
- IPO year
- 2000
- Website
- intuitive.com
Financial highlights
Full financialsIn fiscal 2025, Intuitive Surgical generated $10.06 billion in revenue, up 20.5% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $2.86 billion (+23.0% year over year), for a net margin of 28.4% versus a median of 25.2% in the prior 5 years. Gross margin was 66.0% (down from 67.5%) and operating margin 29.3%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $10.06B | $8.35B | $7.12B | $6.22B | $5.71B |
| Growth | +20.51% | +17.24% | +14.49% | +8.97% | +31.01% |
| Net income | $2.86B | $2.32B | $1.80B | $1.32B | $1.70B |
| EPS (diluted) | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 |
Analyst forecast
ForecastConsensus (33 analysts)
buy
Avg. price target
$477.47+15.19%
- Strong buy 8
- Buy 17
- Hold 7
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Oct 20, 2026
- EPS estimate
- $2.13
- Last reported (Q2 2026)
- Jul 21, 2026
- EPS actual vs est.
- $2.29 vs —
ISRG news
All ISRG news- Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should KnowNasdaq
- Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise?NasdaqISRG, EW, GKOS
- VUG, WELL, NOW, ISRG: ETF Inflow AlertNasdaqVUG, WELL, NOW, ISRG
- Intuitive Surgical: The Multiple Fell, The Story Didn'tSeeking Alpha
- Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher ScientificNasdaqISRG, TMO, GMED
- Inspire Medical Gains New CPT Codes for Hypoglossal Nerve StimulationNasdaqINSP, ISRG, WST, GMED
- 2 Beaten-Down Stocks Worth Buying and Holding for the Next DecadeNasdaqISRG, NFLX, JNJ, MDT
- 3 Medical Instruments Stocks Using GenAI to Navigate Industry WoesNasdaqISRG, TMO, GMED
Intuitive Surgical peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| EWEdwards Lifesciences Corporation | 85.78 | -0.81% | $49.44B | vs ISRG |
| STESTERIS plc (Ireland) | 209.68 | +0.49% | $20.44B | vs ISRG |
| ZBHZimmer Biomet Holdings Inc. | 88.49 | -1.33% | $16.88B | vs ISRG |
| MASMasco Corporation | 68.87 | -1.52% | $13.58B | vs ISRG |
| AITApplied Industrial Technologies Inc. | 334.58 | -3.02% | $12.29B | vs ISRG |
| SNNSmith & Nephew SNATS Inc. | 26.89 | +0.07% | $11.25B | vs ISRG |
| ALGNAlign Technology Inc. | 139.87 | -1.12% | $9.94B | vs ISRG |
| MSAMSA Safety Incorporated | 179.28 | -1.74% | $6.92B | vs ISRG |
Indexes, lists and sector
Index membership
Intuitive Surgical stock FAQ
What is Intuitive Surgical's stock price today?
ISRG last traded at $414.52 as of Oct 7, 4:00 PM EDT, up 2.41% on the day. Prices are delayed at least 15 minutes.
Does Intuitive Surgical pay a dividend?
No. Intuitive Surgical does not currently pay a regular cash dividend.
When is Intuitive Surgical's next earnings date?
Intuitive Surgical is expected to report earnings on Tuesday, October 20, 2026. Analysts expect EPS of $2.13.
What is ISRG's P/E ratio?
ISRG trades at a trailing P/E ratio of 47.54 and a forward P/E of 34.23, compared with a median of 23.3 for its closest peers.
Is Intuitive Surgical in the S&P 500?
Yes. Intuitive Surgical (ISRG) is a constituent of the S&P 500 index.
Who is Intuitive Surgical's CEO?
Mr. David J. Rosa is the chief executive officer of Intuitive Surgical Inc., which has about 17,021 employees.
Has ISRG ever split its stock?
Yes. The most recent ISRG stock split was a 3-for-1 split on Oct 5, 2021, one of 3 splits on record.